1 – 11 of 11
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Thyroid disease in ANCA-associated vasculitis : a clinical and epidemiological study
(
- Contribution to journal › Article
- 2023
-
Mark
High risk of stroke in ANCA-Associated vasculitis-a population-based study
(
- Contribution to journal › Article
-
Mark
Predictors of hypogammaglobulinemia in ANCA-associated vasculitis after a rituximab-based induction : a multicentre study
(
- Contribution to journal › Article
- 2022
-
Mark
The Role of Sural Nerve Biopsy in the Diagnosis of Vasculitis
(
- Contribution to journal › Article
-
Mark
The Sound of Interconnectivity; The European Vasculitis Society 2022 Report
(
- Contribution to journal › Article
- 2019
-
Mark
Efficacy and safety of rituximab in the treatment of eosinophilic granulomatosis with polyangiitis
(
- Contribution to journal › Article
- 2017
-
Mark
Severe infection in antineutrophil cytoplasmic antibody-associated vasculitis
(
- Contribution to journal › Article
-
Mark
Pulmonary involvement in antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis : The influence of ANCA subtype
(
- Contribution to journal › Article
-
Mark
Association of a TNFSF13B (BAFF) regulatory region single nucleotide polymorphism with response to rituximab in antineutrophil cytoplasmic antibody-associated vasculitis
(
- Contribution to journal › Letter
- 2015
-
Mark
Alemtuzumab as Remission Induction Therapy in Behçet Disease: A 20-year Experience.
(
- Contribution to journal › Article
- 2014
-
Mark
Long-Term Follow-Up of Cyclophosphamide Compared with Azathioprine for Initial Maintenance Therapy in ANCA-Associated Vasculitis.
(
- Contribution to journal › Article